(Q24250119)

1

0 references

Max H Pittler

2

0 references

Niall Wilson

3

0 references

Christel van Gool

4

0 references

Rosemary Humphreys

Cochrane Database of Systematic Reviews

5

0 references

publication date

22 April 2003

0 references

published in

0 references

cites work

Childhood atopic eczema

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Topical corticosteroid phobia in patients with atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Cost of atopic dermatitis and eczema in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

The usage of complementary therapies by dermatological patients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Effects of diets enriched in n-6 or n-3 fatty acids on cholesterol metabolism in older rats chronically fed a cholesterol-enriched diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Atopic eczema and domestic water hardness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Antitumor activity of oenothein B, a unique macrocyclic ellagitannin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Sleep difficulties and their management in preschoolers with atopic eczema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Atopic eczema: its impact on the family and financial cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

The unfavorable effects of concomitant asthma and sleeplessness due to the atopic eczema/dermatitis syndrome (AEDS) on quality of life in subjects allergic to house-dust mites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Current management and therapy of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Childhood eczema: disease of the advantaged?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Attitudes and prior experience with respect to alternative medicine among dermatological patients: the Freiburg questionnaire on attitudes to naturopathy (FAN)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

The pathogenesis of atopic eczema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

The early phase of epidermal barrier regeneration is faster in patients with atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Immunopharmacology of the atopic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Reduced levels of prostaglandin precursors in the blood of atopic patients: defective delta-6-desaturase function as a biochemical basis for atopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Skin barrier function in patients with completely healed atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Atopic eczema and the home environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Potential risk of prolonged gamma-linolenic acid use

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

Essential fatty acid metabolism and its modification in atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416

inferred from DOI database lookup

7 January 2021

based on heuristic

Systematic review of treatments for atopic eczema.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004416